Literature DB >> 26756041

Synthesis of ROS scavenging microspheres from a dopamine containing poly(β-amino ester) for applications for neurodegenerative disorders.

Ben Newland1, Paul Wolff2, Dezhong Zhou3, Wei Wang3, Hong Zhang3, Anne Rosser4, Wenxin Wang5, Carsten Werner2.   

Abstract

Parkinson's disease (PD) is a common neurodegenerative disease characterized by a substantial decrease of dopaminergic neurons in the substantia nigra pars compacta. The neurological deterioration during PD can be, in part, attributed to elevated levels of reactive oxygen species (ROS). Radical scavengers have previously been shown to protect dopaminergic cells from toxic effects in vitro. Hence, new approaches need to be investigated to improve the administration of antioxidants in order to provide neuroprotection. Polymers exhibiting catechol structures offer one such approach due to their interesting physicochemical properties. In the present study a photocrosslinkable dopamine-containing poly(β-amino ester) (DPAE) was synthesized from poly(ethylene glycol) diacrylate (PEGDA) and dopamine hydrochloride using Michael type addition. A water-in-oil emulsion technique was used to photo-crosslink the polymer into spherical microparticles. DPAE microspheres featured excellent scavenging properties towards 1,1-Diphenyl-2-picryl-hydrazyl (DPPH) radicals in a dose dependent manner and could even reduce the dissolved oxygen content of physiological solution. Furthermore, the concentrations required for radical scavenging were shown to be non-toxic towards dopaminergic SH-SY5Y cells as well as primary astrocytes and primary embryonic rat ventral midbrain cultures.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26756041      PMCID: PMC5657472          DOI: 10.1039/c5bm00542f

Source DB:  PubMed          Journal:  Biomater Sci        ISSN: 2047-4830            Impact factor:   6.843


  24 in total

1.  Neuronal uptake and intracellular superoxide scavenging of a fullerene (C60)-poly(2-oxazoline)s nanoformulation.

Authors:  Jing Tong; Matthew C Zimmerman; Shumin Li; Xiang Yi; Robert Luxenhofer; Rainer Jordan; Alexander V Kabanov
Journal:  Biomaterials       Date:  2011-02-20       Impact factor: 12.479

2.  The reduction in immunogenicity of neurotrophin overexpressing stem cells after intra-striatal transplantation by encapsulation in an in situ gelling collagen hydrogel.

Authors:  Deirdre B Hoban; Ben Newland; Teresa C Moloney; Linda Howard; Abhay Pandit; Eilís Dowd
Journal:  Biomaterials       Date:  2013-09-17       Impact factor: 12.479

3.  Development of poly(β-amino ester)-based biodegradable nanoparticles for nonviral delivery of minicircle DNA.

Authors:  Michael Keeney; Sang-Ging Ong; Amanda Padilla; Zhenyu Yao; Stuart Goodman; Joseph C Wu; Fan Yang
Journal:  ACS Nano       Date:  2013-07-16       Impact factor: 15.881

Review 4.  SH-SY5Y human neuroblastoma cell line: in vitro cell model of dopaminergic neurons in Parkinson's disease.

Authors:  Hong-rong Xie; Lin-sen Hu; Guo-yi Li
Journal:  Chin Med J (Engl)       Date:  2010-04-20       Impact factor: 2.628

Review 5.  Redox-active radical scavenging nanomaterials.

Authors:  Ajay Karakoti; Sanjay Singh; Janet M Dowding; Sudipta Seal; William T Self
Journal:  Chem Soc Rev       Date:  2010-08-17       Impact factor: 54.564

6.  Re-evaluation of the 2,2-diphenyl-1-picrylhydrazyl free radical (DPPH) assay for antioxidant activity.

Authors:  J Xie; K M Schaich
Journal:  J Agric Food Chem       Date:  2014-05-05       Impact factor: 5.279

7.  Functionalized composite scaffolds improve the engraftment of transplanted dopaminergic progenitors in a mouse model of Parkinson's disease.

Authors:  Ting-Yi Wang; Kiara F Bruggeman; Jessica A Kauhausen; Alexandra L Rodriguez; David R Nisbet; Clare L Parish
Journal:  Biomaterials       Date:  2015-09-30       Impact factor: 12.479

8.  Effective GDNF brain delivery using microspheres--a promising strategy for Parkinson's disease.

Authors:  E Garbayo; C N Montero-Menei; E Ansorena; J L Lanciego; M S Aymerich; M J Blanco-Prieto
Journal:  J Control Release       Date:  2008-12-25       Impact factor: 9.776

9.  Neuromelanin biosynthesis is driven by excess cytosolic catecholamines not accumulated by synaptic vesicles.

Authors:  D Sulzer; J Bogulavsky; K E Larsen; G Behr; E Karatekin; M H Kleinman; N Turro; D Krantz; R H Edwards; L A Greene; L Zecca
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-24       Impact factor: 11.205

10.  Magnetically Controllable Polymer Nanotubes from a Cyclized Crosslinker for Site-Specific Delivery of Doxorubicin.

Authors:  Ben Newland; Daniel Leupelt; Yu Zheng; Laurent S V Thomas; Carsten Werner; Martin Steinhart; Wenxin Wang
Journal:  Sci Rep       Date:  2015-12-01       Impact factor: 4.379

View more
  5 in total

Review 1.  Neuroprotection and antioxidants.

Authors:  Maria Lalkovičová; Viera Danielisová
Journal:  Neural Regen Res       Date:  2016-06       Impact factor: 5.135

2.  Injectable Glycosaminoglycan-Based Cryogels from Well-Defined Microscale Templates for Local Growth Factor Delivery.

Authors:  Ben Newland; Heike Newland; Francesca Lorenzi; Dimitri Eigel; Petra B Welzel; Dieter Fischer; Wenxin Wang; Uwe Freudenberg; Anne Rosser; Carsten Werner
Journal:  ACS Chem Neurosci       Date:  2021-03-23       Impact factor: 4.418

3.  Neuroprotective effects of ganoderma lucidum polysaccharides against oxidative stress-induced neuronal apoptosis.

Authors:  Xin-Zhi Sun; Ying Liao; Wei Li; Li-Mei Guo
Journal:  Neural Regen Res       Date:  2017-06       Impact factor: 5.135

4.  Oxygen producing microscale spheres affect cell survival in conditions of oxygen-glucose deprivation in a cell specific manner: implications for cell transplantation.

Authors:  Heike Newland; Dimitri Eigel; Anne E Rosser; Carsten Werner; Ben Newland
Journal:  Biomater Sci       Date:  2018-09-25       Impact factor: 6.843

5.  Well-Defined Polyethylene Glycol Microscale Hydrogel Blocks Containing Gold Nanorods for Dual Photothermal and Chemotherapeutic Therapy.

Authors:  Ben Newland; Johannes Starke; Chiara Bastiancich; Diana P N Gonçalves; Laura J Bray; Wenxin Wang; Carsten Werner
Journal:  Pharmaceutics       Date:  2022-02-28       Impact factor: 6.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.